Radiation research favours Novoste, say analysts
This article was originally published in Clinica
Despite concerns over the safety of intravascular radiation in certain patients and inconveniences associated with gamma-based systems, the technology should find acceptance in cardiac cath labs, according to investment firm Morgan Stanley Dean Witter.
You may also be interested in...
Dr Reddy's is poised to expand its OTC offering in Russia and certain CIS countries by snapping up a basket of allergy brands from India's Glenmark.
Second read-out maintains 94% level of efficacy, with a very early signal that it could outperform Pfizer’s rival mRNA candidate in preventing severe cases.
The French major and Regeneron have racked up another indication for Dupixent with the blockbuster getting approval in Europe to treat children with severe eczema.